由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - [MNKD] A Giant Leap for MannKind
相关主题
mnkd delayed FDA decision老牛, 估计ACUR明天能反弹到什么价格?
MNKD 振幅巨大医保部
2010 bio四大热点 (转载)FDA play秘诀
MNKD 要卖出18M share 来减少债务买点YGE了,呵呵呵
MNKD咋了?突然就跳水了?Options Update for American Axle & Manufacturing Holdings Inc. (AXL)
下周生拉关注/持有名单, 请大/专家发表意见集思广益:反弹最暴力的股票
Anyone familiar with MNKD?Barrons: A Buy Signal for Stocks Is Emerging (ZT)
有人关注MNKD吗?1季度FDA每日观察
相关话题的讨论汇总
话题: mannkind话题: mnkd话题: put话题: call话题: giant
1 (共1页)
t*******o
发帖数: 1464
t*******o
发帖数: 1464
2
这两天股价移动 今天+6%
t*******o
发帖数: 1464
3
5/21
Interesting Options Volume for MannKind Corporation (MNKD)
NEW YORK (Market Intellisearch) -- MNKD options saw interesting call
activity today. A total of 1,967 put and 8,881 call contracts were traded
raising a low Put/Call volume alert. Today's traded Put/Call ratio is 0.22.
There were 4.51 calls traded for each put contract.
Options can be used as predictors of stock behavior. Investors can use Put/
Call ratios as technical indicators to read for signs of institutional
sentiment. The Put/Call ratios offer insight to investors and can be used as
either a direct or contrarian indicator for trading decisions. Unusual
volume provides reliable clues that the stock is expected to make a move.
Shares of MannKind Corporation closed at $4.94 in the previous trading
session and opened today at $4.87. MNKD is currently trading at $4.95, up $0
.01 (+0.20%) in today's trading session. The shares of the stock are trading
between $4.82 and $5.24. Today's volume of 2,314,294 shares is greater than
the average volume of 2,113,750 shares. The technical momentum Relative
Strengh Index indicator shows oversold conditions. MNKD is trading below the
50 day moving average and lower than the 200 day moving average. The stock'
s 52 week low is $4.91 and 52 week high is $12.30.
Q********8
发帖数: 497
4
难道糖尿病的春天来了。

【在 t*******o 的大作中提到】
: 这两天股价移动 今天+6%
t*******o
发帖数: 1464
5
关键词FDA meeting "early June"
Whether or not MannKind can use that data for the Dreamboat device in their
resubmission to the FDA will be clarified in a face to face meeting with the
FDA in ‘early June.’ If that meeting goes as MannKind expects, they will
file their resubmission within a few weeks after. According to MannKind, at
least two potential Big Pharma partners have been helping them with
preparations for that face to face meeting.
1 (共1页)
相关主题
1季度FDA每日观察MNKD咋了?突然就跳水了?
一些药股的基础野鸡下周生拉关注/持有名单, 请大/专家发表意见
***********2/08-2/12 选股大赛**************Anyone familiar with MNKD?
who's interested in this dagger MNKD有人关注MNKD吗?
mnkd delayed FDA decision老牛, 估计ACUR明天能反弹到什么价格?
MNKD 振幅巨大医保部
2010 bio四大热点 (转载)FDA play秘诀
MNKD 要卖出18M share 来减少债务买点YGE了,呵呵呵
相关话题的讨论汇总
话题: mannkind话题: mnkd话题: put话题: call话题: giant